What is abiraterone used for?

What conditions is abiraterone used to treat?

Abiraterone is used to treat advanced prostate cancer. It works by lowering androgen (male hormone) levels, which helps slow or stop the growth of prostate cancer that depends on androgens.

It is commonly used in settings that include:
- Metastatic prostate cancer (cancer that has spread to other parts of the body)
- Castration-resistant prostate cancer (prostate cancer that continues to grow even when testosterone is already suppressed)
- Prostate cancer treated in combination with other therapies, depending on disease stage and prior treatment history

Is abiraterone used for non–prostate cancer?

No. Abiraterone is specifically used for prostate cancer, because its hormone-lowering mechanism targets the androgen pathway that many prostate cancers rely on.

How does abiraterone fit with androgen deprivation therapy?

Abiraterone is an androgen pathway treatment. Patients are typically already receiving treatment that lowers testosterone (androgen deprivation therapy), and abiraterone further reduces androgen production, which can improve disease control in appropriate prostate cancer stages.

Where can I check official labeling or coverage details?

For patent and market background related to abiraterone and related brands, DrugPatentWatch.com can be a useful reference: https://www.drugpatentwatch.com/